Acta Med. 2021, 64: 227-231

https://doi.org/10.14712/18059694.2022.7

Dual Fungal Infections (Aspergillosis and Mucormycosis) in a Diabetic Mellitus Patient Leading to Maxillary Sinusitis as a Post-COVID Manifestation: First Case Report

Manveen Kaur Jawandaa, Ravi Narulab, Sonia Guptac, Vineet Sharmad, Priya Guptae, Manpreet Kaure

aDepartment of Oral Pathology & Microbiology and Forensic Odontology. Laxmi bai institute of dental sciences and hospital, Patiala, Punjab, India
bDepartment of Oral and Maxillofacial surgery, Guru Nanak Dev Dental College and Research Institute, Sunam, Punjab, India
cDepartment of Oral Pathology and Microbiology & Forensic Odontology, Rayat and Bahra dental college and hospital, Mohali, Punjab, India
dDepartment of Conservative Dentistry, Laxmi bai institute of dental sciences and hospital, Patiala, Punjab, India
eDepartment of Oral and Maxillofacial Pathology & Microbiology, Laxmi Bai Institute of Dental Sciences and Hospital, Patiala, Punjab, India

Received August 31, 2021
Accepted December 1, 2021

References

1. Amorim Dos Santos J, Normando AGC, et al. Oral Manifestations in Patients with COVID-19: A Living Systematic Review. J Dent Res 2021; 100(2): 141–54. <https://doi.org/10.1177/0022034520957289>
2. Pathak K, Karadwal A, Nayak P, Nayak S. Mucormycosis in Post Covid Patient - A Case Report. Indian J Forens Med Toxicol 2021; 15(3): 240–4.
3. Prestel C, Anderson E, Forsberg K, et al. Candida auris outbreak in a COVID-19 specialty care unit – Florida, July–August 2020. Morbidity and Mortality Weekly Report. 2021; 70(2): 56–7. <https://doi.org/10.15585/mmwr.mm7002e3> <PubMed>
4. Moorthy A, Gaikwad R, Krishna S, et al. SARS-CoV-2, uncontrolled diabetes and corticosteroids-An unholy trinity in invasive fungal infections of the maxillofacial region? A Retrospective, Multi-centric Analysis. J Maxillofac Oral Surg 2021; 20(3): 1–8. <https://doi.org/10.1007/s12663-021-01532-1> <PubMed>
5. Wolff D, Nee S, Hickey NS, Marschollek M. Risk factors for Covid-19 severity and fatality: a structured literature review. Infection 2021; 49(1): 15–28. <https://doi.org/10.1007/s15010-020-01509-1> <PubMed>
6. Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020; 8(4): 420–2. <https://doi.org/10.1016/S2213-2600(20)30076-X> <PubMed>
7. Peeri NC, Shrestha N, Rahman MS, et al. The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? Int J Epidemiol 2020; 49(3): 717–26. <https://doi.org/10.1093/ije/dyaa033> <PubMed>
8. Li CS, Pan SF. Analysis and causation discussion of 185 severe acute respiratory syndrome dead cases. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2003; 15(10): 582–4. In Chinese.
9. Mehta S, Pandey A. Rhino-orbital mucormycosis associated with COVID-19. Cureus 2020; 12: e10726.
10. Jagtap SV, Jagtap SS, Nagar V, Varshney K. Invasive mucormycosis in post COVID-19 infection: Case report with review. IP Arch Cytol Histopathology Res 2021; 6(2): 135–9. <https://doi.org/10.18231/j.achr.2021.033>
11. Hingad N, Kumar G, Deshmukh R. Oral mucormycosis causing necrotizing lesion in a diabetic patient: a case report. Int J Oral Maxillofac Pathol 2012; 3(3): 8–12.
12. Muzyka BC, Epifanio RN. Update on oral fungal infections. Dental clinics of North America 2013; 57(4): 561–81. <https://doi.org/10.1016/j.cden.2013.07.002>
13. Rajendra Santosh AB, Muddana K, Bakki SR. Fungal infections of oral cavity: Diagnosis, management, and association with COVID-19. SN Compr Clin Med 2021 Mar 27: 1-12.
14. Deepa A, Nair BJ, Sivakumar T, Joseph AP. Uncommon opportunistic fungal infections of oral cavity: a review. J Oral Maxillofac Pathol 2014; 18(2): 235–43. <https://doi.org/10.4103/0973-029X.140765> <PubMed>
15. Vučićević Boras V, Jurlina M, Brailo V, Đurić Vuković K, et al. Oral mucormycosis and aspergillosis in the patient with acute leukemia. Acta Stomatologica Croatica 2019; 53(3): 274–7. <https://doi.org/10.15644/asc53/3/9> <PubMed>
16. Bathoorn E, Escobar Salazar N, Sepehrkhouy S, Meijer M, de Cock H, Haas PJ. Involvement of the opportunistic pathogen Aspergillus tubingensis in osteomyelitis of the maxillary bone: a case report. BMC Infect Dis 2013; 13: 59. <https://doi.org/10.1186/1471-2334-13-59> <PubMed>
17. Jenks JD, Hoenigl M. Treatment of Aspergillosis. J Fungi (Basel) 2018; 4(3): 98. <https://doi.org/10.3390/jof4030098> <PubMed>
18. EI Kohley NA, El-Fattah AMA, Khafagy YK. Invasive Fungal Sinusitis in Post COVID-19 Patients: A New Clinical Entity. Laryngoscope 2021; 00: 1–7.
19. Baruah C, Devi P, Deka B, Sharma DK. Mucormycosis and Aspergillosis have been linked to Covid- 19-related fungal infections in India. Adv Case Stud 2021; 3(1): AICS.000555.
20. Unnikrishnan R, Misra A. Infections and diabetes: risks and mitigation with reference to India. Diab Metabol Synd Clin Res Rev 2020; 14: 1889–94.
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal

Archive